Research dossier
Kisspeptin-10 — KISS1R receptor dossier
The minimal active fragment of a peptide central to the regulation of the reproductive axis.
Translated from the French original, which remains the reference version: lire en français →
Molecular identity
| Parameter | Value |
|---|---|
| CAS number | 374675-21-5 |
| Molar mass | 1302.45 g/mol |
| Molecular formula | C₆₃H₈₃N₁₇O₁₄ |
| Sequence / nature | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ |
| Purity | ≥99% |
| Appearance | White lyophilised powder |
The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.
Research context
The identification of the kisspeptin/KISS1R system changed the understanding of how the reproductive axis is regulated, by placing a control point upstream of GnRH. The 1-10 fragment has become the standard tool of that field, which makes it a compound frequently used as a methodological reference.
Mechanism studied
Kisspeptin-10 corresponds to the ten C-terminal residues of kisspeptin-54, the fragment identified as the minimal motif retaining affinity for the receptor. That portion carries the characteristic RF-amide motif, whose C-terminal amidation is indispensable to binding.
The KISS1R receptor, initially designated GPR54, is a Gq protein-coupled receptor. Its activation triggers the phospholipase C pathway with calcium mobilisation, measurable in culture by calcium imaging.
The literature describes this system as a control point upstream of GnRH secretion, which makes it a central object of study in reproductive neuroendocrinology. The published in-vitro work covers cell lines expressing recombinant human KISS1R, with measurement of calcium or of IP1 accumulation, as well as primary hypothalamic cultures.
A recurring methodological point concerns stability: the peptide is sensitive to endopeptidases and the loss of the terminal amidation abolishes activity.
In-vitro literature
The reference assays are conducted on the recombinant human receptor. Primary hypothalamic cultures provide a more physiological context but lower reproducibility.
Bibliographic entry points
- PubMed — peer-reviewed literature
- PubChem — chemical profile and assay data
- NCBI — methodology and receptor references
These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.
Distinguishing this compound from its analogues
Kisspeptin-10 is the C-terminal fragment of kisspeptin-54. The two forms share the active motif but differ in stability and in kinetics.
The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.
Methodological limits
The loss of the C-terminal amidation abolishes activity while changing the mass by only 1 Da — a gap that can go unnoticed on a spectrum of insufficient resolution. It is the principal cause of inactive material reported for this peptide. Sensitivity to endopeptidases also makes it necessary to control the effective duration of exposure.
These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.
Analytical parameters
The C-terminal amidation must be confirmed by mass spectrometry: the free acid form, a frequent synthesis impurity, has a mass 1 Da lower and does not have the same binding properties.
| Parameter | Value |
|---|---|
| Storage | Store at −20 °C, protected from light |
| Solubility | Soluble in bacteriostatic water (BAC) |
| Stability | Stable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C |
| Control methods | RP-HPLC · MS · NMR |
Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.
Resulting concentrations
The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.
| Format | 1 ml | 2 ml | 3 ml |
|---|---|---|---|
| 10mg | 10.00 mg/ml | 5.00 mg/ml | 3.33 mg/ml |
These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.
Protocol design
Three points govern the validity of an assay using this material, whatever the question being asked.
The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.
The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.
The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.
Lot verification
The following formats are covered by a Janoshik Analytical report, readable from the product page:
- 10mg — lot report available
| Format | Lot report | Availability |
|---|---|---|
| 10mg | Covered | In stock |
The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.
Frequently asked questions
How does this product arrive?
As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.
Which solvent should be used for reconstitution?
Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.
How long does the material remain stable?
The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.
Does the analysis report correspond exactly to my vial?
The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.
Can this product be used on humans or animals?
No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.
Dossiers in the same category
- Oxytocin — CAS 50-56-6